|
"chung cy"的相關文件
顯示項目 11-20 / 28 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2012-09-18 |
Probing the dynamics of doxorubicin-DNA intercalation during the initial activation of apoptosis by Fluorescence Lifetime Imaging Microscopy (FLIM)
|
Chen, NT;Wu, CY;Chung, CY;Hwu, Y;Cheng, SH;Mou, CY;Lo, LW |
| 國立臺灣海洋大學 |
2012 |
Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.
|
Liu HY; Chung CY; Yang WC; Liang CL; Wang CY; Chang CY; Chang CL. |
| 國家衛生研究院 |
2011-10 |
Recent advances in dynamic monitoring of drug release of nanoparticle using forster resonance energy transfer and fluorescence lifetime imaging
|
Cheng, SH;Chen, NT;Wu, CY;Chung, CY;Hwu, Y;Mou, CY;Yang, CS;Lo, LW |
| 國家衛生研究院 |
2011-07 |
Simple mobile single-sided NMR apparatus with a relatively homogeneous B0 distribution
|
Chang, WH;Chung, CY;Chen, JH;Hwang, DW;Hsu, CH;Yao, C;Hwang, LP |
| 國家衛生研究院 |
2011-03-29 |
Probing the binding kinetics of proinflammatory cytokine-antibody interactions using dual color fluorescence cross correlation spectroscopy
|
Wu, CY;Huang, CK;Chung, CY;Huang, IP;Hwu, Y;Yang, CS;Lai, YK;Lo, LW;Chiang, SY |
| 國立聯合大學 |
2010 |
Physical and dielectric properties of sol-gel derived ZnO-doped Zr0.8Sn0.2TiO4 dielectric thin films
|
Hsu, CH; Chung, CY |
| 高雄醫學大學 |
2008 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy
|
黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. |
| 臺北醫學大學 |
2006 |
Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53
|
賴文福; Deng WP; Chao MW; Lai WF; Sun C; Chung CY; Wu CC; Lin IH; Hwang JJ; Wu CH; Chiu WT; Chen CY; |
| 臺北醫學大學 |
2006 |
Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53
|
鄧文炳; Deng WP; Chao MW; Lai WF; Sun C; Chung CY; Wu CC; Lin IH; Hwang JJ; Wu CH; Chiu WT; Chen CY |
| 國立臺灣大學 |
2005-06 |
Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer.
|
Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. |
顯示項目 11-20 / 28 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
